Maplight Therapeutics, Inc. · NASDAQ:MPLT
Gillis Jonathan received 8,242 Maplight Therapeutics, Inc. shares as an award (Form 4)
Traded Aug 17, 2026 · Filed Aug 19, 2026
On Aug 17, 2026, Gillis Jonathan (CAO and Interim CFO) received 8,242 Maplight Therapeutics, Inc. shares as an award, leaving 152,482 shares. Filed Aug 19, 2026 (Form 4).
- Awarded
- 8,242 shares
- Holding after
- 152,482 shares
- Trading plan
- No
- Role
- CAO and Interim CFO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Voting Common Stock | Award | 6,020 | 150,260 | Direct | |
| Aug 17, 2026 | Voting Common Stock | Award | 2,222 | 152,482 | Direct |
Source
Related
- Maplight Therapeutics, Inc.
- Gillis Jonathan
- Maplight Therapeutics, Inc. shareholders
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Gillis Jonathan · Jul 20, 2026
- Form 4 · Gillis Jonathan · Apr 29, 2026
- Form 4 · Gillis Jonathan · Apr 17, 2026
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Oct 16, 2026
- Form 4 · Lillie James Woodruff · Oct 16, 2026